Andrea A Martoni Selected Research

Therapeutics

1/2007

The predictive value of 18F-FDG-PET early evaluation in patients with metastatic gastric adenocarcinoma treated with chemotherapy plus cetuximab.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrea A Martoni Research Topics

Disease

4	Neoplasms (Cancer) 03/2018 - 02/2010
2	Breast Neoplasms (Breast Cancer) 02/2010 - 09/2006
1	Death (Near-Death Experience) 01/2017
1	Pathologic Complete Response 02/2010
1	Residual Neoplasm 02/2010
1	Disease Progression 01/2007
1	Adenocarcinoma 01/2007
1	Stomach Neoplasms (Stomach Cancer) 01/2007
1	Liver Failure 09/2006

Drug/Important Bio-Agent (IBA)

2	Estrogens (Estrogen)FDA Link 02/2010 - 09/2006
1	Estrogen ReceptorsIBA 02/2010
1	Cetuximab (Erbitux)FDA Link 01/2007
1	thiamine triphosphorate (TTP)IBA 01/2007
1	Trastuzumab (Herceptin)FDA Link 09/2006

Therapy/Procedure

4	Drug Therapy (Chemotherapy) 01/2017 - 09/2006
2	Palliative Care (Palliative Therapy) 03/2018 - 01/2018
1	Therapeutics 01/2007
1	Salvage Therapy 09/2006